Van der Hoek et al. were among the first to demonstrate that SSTR5 plays a dominant role in regulating ACTH secretion in corticotroph tumor cells, showing that the selective activation of SSTR5 more effectively inhibits ACTH release compared to SSTR2 activation in vitro [70]. Here, POMC is linked to neoplasm.